BBLG Q1 2018 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q1 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-0.03

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$818,875

Free Cash Flow

-$818,875

Stock-Based Comp.

$195,795

Balance Sheet

Total Assets

$470,495

Total Liabilities

$9M

Stockholders' Equity

-$9M

Cash & Equivalents

$371,404

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$1M	-$2M	+49.2%
Net Income	-$1M	-$3M	+52.7%